Alternative affinity tools: more attractive than antibodies?
about
Selection and Biosensor Application of Aptamers for Small MoleculesElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsBiota and biomolecules in extreme environments on Earth: implications for life detection on MarsSmart materials based on DNA aptamers: taking aptasensing to the next levelUnderstanding FRET as a research tool for cellular studiesAptamers as a sensitive tool to detect subtle modifications in therapeutic proteinsGeneration of Novel Hybrid Aptamer-Molecularly Imprinted Polymeric NanoparticlesEmerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound AgentShort peptides as biosensor transducers.Direct validation of aptamers as powerful tools to image solid tumorRNA based antagonist of NMDA receptorsDevelopment of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays.Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.Chromatographic immunoassays: strategies and recent developments in the analysis of drugs and biological agents.Proteomics-based methods for discovery, quantification, and validation of protein-protein interactions.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin.A cooperative-binding split aptamer assay for rapid, specific and ultra-sensitive fluorescence detection of cocaine in saliva.Site-specific labeling of DNA and RNA using an efficiently replicated and transcribed class of unnatural base pairs.Synthetic mammalian gene networks as a blueprint for the design of interactive biohybrid materials.Reporter-based screening and selection of enzymes.Performance limitations for nanowire/nanoribbon biosensors.Molecular imprinting science and technology: a survey of the literature for the years 2004-2011.A mass spectrometry view of stable and transient protein interactions.Kinetic and stoichiometric characterisation of streptavidin-binding aptamers.Generation of ribosome imprinted polymers for sensitive detection of translational responses.Automatic reactor for solid-phase synthesis of molecularly imprinted polymeric nanoparticles (MIP NPs) in water.One-Step Facile Synthesis of Aptamer-Modified Graphene Oxide for Highly Specific Enrichment of Human A-Thrombin in Plasma.Size dependent targeted delivery of gold nanoparticles modified with the IL-6R-specific aptamer AIR-3A to IL-6R-carrying cells.Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics.Whole cell-SELEX of aptamers with a tyrosine-like side chain against live bacteria.A two-step strategy to visually identify molecularly imprinted polymers for tagged proteins.Aptamer-Based Microfluidic Electrochemical Biosensor for Monitoring Cell-Secreted Trace Cardiac Biomarkers.Optical sensors with molecularly imprinted nanospheres: a promising approach for robust and label-free detection of small molecules.Aptamer Technology: Adjunct Therapy for Malaria.Label-free affinity biosensor arrays: novel technology for molecular diagnostics.
P2860
Q26744467-A91323B9-C99E-48D9-A155-AEDF05BC5D6DQ26822552-6D9BC414-FE49-4BA7-9988-6DE9ADAE207DQ26862566-FF2DDD24-3D30-4D4C-82BC-803FB1BE557DQ27011878-9C6FBC9E-B034-4BE1-B43B-A345707FA88DQ28088633-7FE85648-8F94-47F8-9085-E09F4DAAA01FQ28481282-9672DFAE-8BCA-423F-95A7-DADC20D4BF69Q29399137-899956D8-C644-4B94-B767-6E08721EF92CQ30234679-CBB16A90-05F7-4B59-A77E-8C93DEFED964Q30375870-B77A0168-5520-43A8-9D55-CDEB4B7ABDC4Q31043462-DFB29D02-801A-48CC-9FA1-24E39681FEBDQ33632641-A5145671-7303-43BB-AF94-91C592791E23Q33918208-A3FB2164-43B9-4792-9DC8-080344287A26Q34291876-74A1C963-34BD-4658-B8E0-B5D4762C2B73Q34608038-2890A5E0-106A-483B-BBD0-0B84DEA230A9Q36095367-6C8665C2-9C39-4A1D-A4EA-07C2D52D0DAEQ36765073-68E3E0A0-9854-49FB-998F-C1883788AC6DQ36884872-7DF80725-D973-4E5B-8AE4-8913A34B337EQ37346447-6E95FBA4-92A9-468B-94E5-744EFB001727Q37361849-E14512E5-62D1-4D02-A530-F5D95E31D1C6Q37641195-A1C4DC10-2751-4849-B0EA-D635AEF6AD57Q37706361-9872FDC0-2527-4741-8C05-DB24DD906F6DQ37926924-0B057CD7-07EB-4E1B-9B9B-785BD04B468FQ38098276-896B5CA0-5339-483F-8E51-109BB8F01AD0Q38125143-D78BB66D-05A5-4BD4-A79A-1126BEE719FBQ38202089-3E8637ED-BC11-4196-A00F-DF8277CEF74CQ38222149-7BC9CB69-B2B0-4628-9D2B-F284F3C77219Q38326894-E568608F-3D0C-4DD6-9935-C106951BA83DQ41141228-4BB43456-5B7F-4C9D-AB8A-2A2F12D7BA5CQ41587338-AA2C40D5-CF5A-4A7C-8DE9-E099BEF3DAA4Q41813777-9784F959-9BD0-4124-9B33-E131475F4F84Q47187038-B0CAE19A-0A2D-48C7-A3AC-E108912F5963Q47351427-E824CA5D-9C61-4DB4-853A-1904DE72C1A6Q48026851-75C34AF7-0A15-41D8-8001-53162A6534F1Q48087924-0527306A-511D-41D1-8264-96EF98DD0395Q48121174-0170968A-E8F5-46A1-859B-6513A31873D3Q48292099-3F8D3392-92EE-43FD-9872-6CB8FB2916BAQ51166866-752289B3-52CE-4A42-9A11-22CD09AD2AFAQ51543731-6C61D47B-B9B1-4E1C-BFB0-EE96E332600BQ52093966-0266AF61-1DF0-4E0A-8FA9-8CE52EDB29F4Q53570743-CA174ED9-6FE0-47C3-A5A2-7E99B2B19C66
P2860
Alternative affinity tools: more attractive than antibodies?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alternative affinity tools: more attractive than antibodies?
@en
Alternative affinity tools: more attractive than antibodies?
@nl
type
label
Alternative affinity tools: more attractive than antibodies?
@en
Alternative affinity tools: more attractive than antibodies?
@nl
prefLabel
Alternative affinity tools: more attractive than antibodies?
@en
Alternative affinity tools: more attractive than antibodies?
@nl
P2860
P50
P356
P1433
P1476
Alternative affinity tools: more attractive than antibodies?
@en
P2093
Michel H M Eppink
Vincent J B Ruigrok
P2860
P356
10.1042/BJ20101860
P407
P577
2011-05-01T00:00:00Z